Pharmaceutical manufacturing plant construction · New York

Pine Pharmaceuticals, 355 Riverwalk

Tonawanda, NY · ~197 workers · 3 years of OSHA Injury Tracking Application data.

B
Good Safety Record
1.6
Avg TCR
2.9
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Pine Pharmaceuticals, 355 Riverwalk runs at 54% of its industry's injury rate - safer than the typical Pharmaceutical manufacturing plant construction workplace, earning a grade B.

Pine Pharmaceuticals, 355 Riverwalk: 1.6 TCR = 54% of Pharmaceutical manufacturing plant construction BLS 2.9 · 3y Form 300A (see methodology below)

Pine Pharmaceuticals, 355 Riverwalk safety composite

Pine Pharmaceuticals, 355 Riverwalk scores strongest on total case rate (tcr) (safer than 51% of same-industry peers) and weakest on dart rate (safer than 36%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

46/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
D 1.57 per 100 workers

Safer than 51% of industry peers

DART rate
D 0.86 per 100 workers

Safer than 36% of industry peers

Fatalities
D 0

Safer than 51% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Pine Pharmaceuticals, 355 Riverwalk: 1.7 → 2.2 TCR

Peak year 2024 @ 2.2 TCR · DART/TCR 0.55× in 2024

Pine Pharmaceuticals, 355 Riverwalk's TCR rose 0.4 from 1.7 in 2022 to 2.2 in 2024. In 2024, DART was 0.55× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 236210 · Tonawanda, NY AT/BELOW-IND · MID

Grade B · TCR 1.6 · 54% of ind

  • DART 0.9 DART
  • RANK #9/29
  • PHOTO IFF
  • BOOK 3y book
  • INJ 8 inj
  • SIZE ~197 FTE

Nearest TCR peer: IFF (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

Pine Pharmaceuticals, 355 Riverwalk in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Pine Pharmaceuticals, 355 Riverwalk averages 1.6 TCR (54% of the Pharmaceutical manufacturing plant construction BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Pine Pharmaceuticals, 355 Riverwalk TCR series: 2022=1.7 · 2023=0.8 · 2024=2.2 · BLS 2.9

Where Pine Pharmaceuticals, 355 Riverwalk falls in its industry

924 Pharmaceutical manufacturing p establishments

Safer than 51% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #9 safest of 29 Pharmaceutical manufacturing p employers in New York.

Pine Pharmaceuticals, 355 Riverwalk (197 employees, TCR 1.6) among 29 same-industry peers, split at the industry median of 71 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,500 05101520 Average employees Total Case Rate Pine Pharmaceuticals, 355 Riverwalk
Pine Pharmaceuticals, 355 Riverwalk (197 employees, TCR 1.6) among 29 same-industry peers, split at the industry median of 71 employees and a TCR of 1.6

Pine Pharmaceuticals, 355 Riverwalk has more employees than the Pharmaceutical manufacturing plant const median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 2.2 0.9 5 0 0
2023 0.8 0.4 2 0 0
2022 1.7 0.0 1 1 0

OSHA ITA peer cross-reference

Establishment peer ledger

236210 · NY · Tonawanda

924 Pharmaceutical manufacturing plant construction employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 134 employers in Tonawanda, NY · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR IFF 1.6 TCR
NAICS-TCR Flach Industries Inc. 1.6 TCR
NAICS-TCR Worley Field Services - ADM Cedar Rapids 1.6 TCR
NAICS-TCR O&M Ticonderoga 1.6 TCR
STATE-SIZE Safeway Construction Enterprises LLC 197 FTE
STATE-SIZE Almar Plumbing & Heating Corp 197 FTE
STATE-SIZE MASPETH NY (PAGE PL) DEPOT 197 FTE
STATE-SIZE 8394 197 FTE
CITY-NEAR Tonawanda Engine Plant 1,623 FTE
CITY-NEAR Sumitomo Rubber USA, LLC 1,396 FTE
CITY-NEAR Praxair Technology Center 1,039 FTE
CITY-NEAR Linde Inc. 986 FTE
NAT-TCR Armstrong World Industries - Marietta Ceiling Plant 1.6 TCR
NAT-TCR CL Trucking & Excavating, LLC 1.6 TCR
NAT-TCR McCarty Landfill 1.6 TCR
NAT-TCR Lasc Suites 1.6 TCR
NAT-SIZE Gagnon, Inc. 197 FTE
NAT-SIZE Martin'S Food Markets 6444 197 FTE
NAT-SIZE Foss Energy Services 197 FTE
NAT-SIZE South Boston 197 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.